Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Erasca Inc. Common Stock (ERAS) vs Paychex, Inc. (PAYX) Price & Performance

Erasca Inc. Common StockTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

Erasca Inc. Common Stock vs Paychex, Inc. — how do they compare? Erasca Inc. Common Stock trades at $15.92 (market cap $5.40B), while Paychex, Inc. trades at $104.11 (market cap $37.19B). The key difference: Paychex, Inc. is far larger — about 6.9× Erasca Inc. Common Stock's market cap, and Paychex, Inc. pays a 4.56% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Paychex, Inc. for 56 Days on average.

ERASPAYX
Market Cap
$5.40B$37.19B
Volume
9,533,1853,344,316
Sector
HealthIndustrials
52-Week High
$22.47$128.59
52-Week Low
$2.20$85.57
Typical Hold Time
0 Days56 Days
Enterprise Value
$5.18B$40.87B
Dividend Yield
—4.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Erasca Inc. Common Stock

No Aura AI signal available yet.

Paychex, Inc.

Paychex (PAYX) trades at $104.62, up 3.02% today, with a mixed technical outlook showing bullish overall signals but bearish moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.34 beating the $1.32 estimate, and maintains robust profitability with a 27.35% net income margin. Recent news highlights a 14% stock decline despite earnings strength, raising questions about dividend sustainability amid investor focus on cash flow.

The outlook is cautiously optimistic, with a consensus price target of $111 suggesting modest upside. Key opportunities include steady revenue growth and high margins, but risks involve labor market sensitivity and elevated valuation multiples. The stock's recent volatility reflects divergent analyst views, with 67.74% holding a neutral rating.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ERAS
50% Buy50% Sell
Avg holding period · 0 Days
PAYX

No sentiment data available yet.

Top news

Latest headlines on both assets

About Erasca Inc. Common Stock

Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.

Read more on ERAS →

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX →